T1	Participants 97 204	patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors
T2	Participants 428 540	patients with rheumatoid arthritis (RA) who had an inadequate response to tumor necrosis factor (TNF) inhibitors
T3	Participants 681 741	PBO-randomized patients were rescued with RTX as appropriate
T4	Participants 743 821	Patients responding to initial RTX treatment could receive further RTX courses
T5	Participants 1243 1279	480 patients received â‰¥ 1 RTX course
